Related Experiment Video

Updated: Jul 18, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

Cardiomyopathy with a unique finding of bicuspid aortic valve in Becker's muscular dystrophy

Cynthia Feeley1, Simon Rasbridge

  • 1Histology Department, Poole Hospital, Longfleet Road, Poole BH15 2JB, United Kingdom. cafeeley@doctors.org.uk <cafeeley@doctors.org.uk>

Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology
|November 23, 2006
PubMed

Insights

This case report details a patient with Becker's muscular dystrophy experiencing cardiac failure. The failure stemmed from dilated cardiomyopathy and a congenital bicuspid aortic valve with stenosis, a previously undocumented association.

Area of Science:

  • Cardiology
  • Neuromuscular Disorders
  • Genetics

Background:

  • Becker's muscular dystrophy is a genetic neuromuscular disorder primarily affecting skeletal muscle.
  • Cardiac involvement, such as dilated cardiomyopathy, is a known complication in dystrophinopathies.
  • Congenital heart defects are typically considered separate from primary neuromuscular conditions.

Observation:

  • A patient diagnosed with Becker's muscular dystrophy presented with significant cardiac failure.
  • Diagnostic evaluation revealed dilated cardiomyopathy.
  • The patient also had a congenital bicuspid aortic valve with associated aortic stenosis.

Findings:

  • This case presents a unique combination of Becker's muscular dystrophy and congenital bicuspid aortic valve with aortic stenosis leading to cardiac failure.
  • No prior documented association exists between congenital valve disease and human dystrophinopathies.
  • This represents the first reported instance of such a co-occurrence.

Implications:

  • This finding may necessitate a re-evaluation of cardiac screening protocols for patients with Becker's muscular dystrophy.
  • Further research is warranted to explore potential genetic or molecular links between dystrophinopathies and congenital heart valve anomalies.
  • Understanding this association could lead to improved diagnostic and management strategies for affected individuals.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...